A Phase 3 Study Comparing Clinical Outcomes in People Living With HIV (PLHIV) With Suboptimal Adherence Treated With Injectable Long-acting Antiretrovirals Versus Oral Antiretrovirals
Latest Information Update: 26 Aug 2024
At a glance
- Drugs Cabotegravir+rilpivirine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms SUPLA
Most Recent Events
- 23 Aug 2024 Status changed from not yet recruiting to recruiting.
- 24 Jul 2024 New trial record